Role of glutamine supplementation in critically ill patients

Current Opinion in Anaesthesiology

Volumn 21, Issue 2, 2008, Pages 155-159

  Wernerman, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Continuous renal replacement therapy; Critically ill; Dipeptides; Glutamate; Glutamine

Indexed keywords

GLUTAMIC ACID; GLUTAMINE;

AMINO ACID BLOOD LEVEL; CRITICAL ILLNESS; DIET SUPPLEMENTATION; HEAD INJURY; HUMAN; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; TOTAL PARENTERAL NUTRITION;

CRITICAL ILLNESS; DIETARY SUPPLEMENTS; GLUTAMINE; HUMANS; PARENTERAL NUTRITION, TOTAL;

EID: 43249114468     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3282f54fd6     Document Type: Review

References (49)

1. van Acker BA, Hulsewe KW, Wagenmakers AJ, et al. Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. J Nutr 2000; 130:1566-1571.
2. van Acker BA, Hulsewe KW, Wagenmakers AJ, et al. Response of glutamine metabolism to glutamine-supplemented parenteral nutrition. Am J Clin Nutr 2000; 72:790-795.
3. Darmaun D, Just B, Messing B, et al. Glutamine metabolism in healthy adult men: response to enteral and intravenous feeding. Am J Clin Nutr 1994; 59:1395-1402.
4. Kreider ME, Stumvoll M, Meyer C, et al. Steady-state and nonsteady-state measurements of plasma glutamine turnover in humans. Am J Physiol 1997; 272 (4 Pt 1): E621-E627.
5. Berg A, Norberg A, Martling CR, et al. Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy. Intensive Care Med 2007; 33:660-666.
6. A study showing that dialysis losses during continuous dialysis in ICU patients do not increase during intravenous supplementation. The study also shows that cumulated losses over time in patients dependent upon continuous dialysis may add up to significant amounts when endogenous production is likely to be insufficient.
7. Van Acker BA, Hulsewe KW, Wagenmakers AJ, et al. Absence of glutamine isotopic steady state: implications for the assessment of whole-body glutamine production rate. Clin Sci (Lond) 1998; 95:339-346.
8. Dechelotte P, Darmaun D, Rongier M, et al. Absorption and metabolic effects of enterally administered glutamine in humans. Am J Physiol 1991; 260 (5 Pt 1): G677-G682.
9. Melis GC, Boelens PG, van der Sijp JR, et al. The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients. Br J Nutr 2005; 94:19-26.
10. Matthews DE, Marano MA, Campbell RG. Splanchnic bed utilization of glutamine and glutamic acid in humans. Am J Physiol 1993; 264 (6 Pt 1): E848-E854.
11. Berg A, Forsberg E, Wernerman J. The local vascular tolerance to an intravenous infusion of a concentrated glutamine solution in ICU patients. Clin Nutr 2002; 21:135-139.
12. Berg A, Rooyackers O, Norberg A, Wernerman J. Elimination kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids 2005; 29:221-228.
13. Tjader I, Berg A, Wernerman J. Exogenous glutamine: compensating a shortage? Crit Care Med 2007; 35 (9 Suppl): S553-S556.
14. An overview suggesting the plasma concentration to guide intravenous glutamine supplementation.
15. Wernerman J. Glutamine to intensive care unit patients. JPEN J Parenter Enteral Nutr 2003; 27:302-303.
16. Lofberg E, Essen P, McNurlan M, et al. Effect of hemodialysis on protein synthesis. Clin Nephrol 2000; 54:284-294.
17. Hlatky R, Goodman JC, Valadka AB, Robertson CS. Role of nitric oxide in cerebral blood flow abnormalities after traumatic brain injury. J Cereb Blood Flow Metab 2003; 23:582-588.
18. Stahl N, Schalen W, Ungerstedt U, Nordstrom CH. Bedside biochemical monitoring of the penumbra zone surrounding an evacuated acute subdural haematoma. Acta Neurol Scand 2003; 108:211-215.
19. Reinstrup P, Stahl N, Mellergard P, et al. Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 2000; 47:701-709; discussion 709-710.
20. Marion DW, Puccio A, Wisniewski SR, et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002; 30:2619-2625.
21. Mendelowitsch A, Sekhar LN, Wright DC, et al. An increase in extracellular glutamate is a sensitive method of detecting ischaemic neuronal damage during cranial base and cerebrovascular surgery: an in vivo microdialysis study. Acta Neurochir (Wien) 1998; 140:349-355; discussion 356.
22. Tjader I, Rooyackers O, Forsberg AM, et al. Effects on skelet al. muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med 2004; 30:266-275.
23. Berg A, Bellander BM, WanecekM, et al. Intravenous glutamine supplementation to head trauma patients leaves cerebral glutamate concentration unaffected. Intensive Care Med 2006; 32:1741-1746.
24. An original study demonstrating that the interstitial glutamate concentration in the brain in head trauma patients is not influenced by exogenous glutamine supplementation. Furthermore there are patients with a high intracerebral glutamate concentration, but the study gives no indication that glutamate level and an unfavourable outcome are connected.
25. Berg A, Bellander B, Wanecek M, et al. Endogenous gluatamine utilisation in head trauma patients. Intensive Care Med 2006; 32:S106.
26. GoetersC, Wenn A, Mertes N, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002; 30:2032-2037.
27. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13:295-302.
28. Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30:2022-2029.
29. Dechelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006; 34:598-604.
30. A French multicentre study over intravenous glutamine supplementation that demonstrates a positive effect upon morbidity. Post-hoc analyses also suggest that glutamine supplementation may decrease insulin resistance.
31. Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003; 27:355-373.
32. HoudijkAP, van Leeuwen PA. Glutamine-enriched enteral nutrition in multiple trauma patients. Nutrition 2000; 16:70-71.
33. Conejero R, Bonet A, Grau T, et al. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition 2002; 18:716-721.
34. Hall JC, Dobb G, Hall J, et al. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med 2003; 29:1710-1716.
35. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition 1999; 15:108-115.
36. Zhou YP, Jiang ZM, Sun YH, et al. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr 2003; 27:241-245.
37. Garrel D, Patenaude J, Nedelec B, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med 2003; 31:2444-2449.
38. van den Berg A, van Elburg RM, Westerbeek EA, et al. Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial. Am J Clin Nutr 2005; 81:1397-1404.
39. Albers MJ, Steyerberg EW, HazebroekFW, et al. Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestive-tract surgery: results from a double-blind, randomized, controlled trial. Ann Surg 2005; 241:599-606.
40. Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics 2004; 113:1209-1215.
41. Duggan C, Stark AR, Auestad N, et al. Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial. Nutrition 2004; 20:752-756.
42. Tubman TR, Thompson SW, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2005; (1): CD001457.
43. Kadrofske MM, Parimi PS, Gruca LL, Kalhan SC. Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period. Am J Physiol Endocrinol Metab 2006; 290:E622-E630.
44. A study in neonatal patients demonstrating that the knowledge of glutamine status and glutamine kinetics in this patient group is not sufficiently understood, which to some extent invalidates the results from the multicentre studies in neonatal patients in the literature.
45. Schroeder J, Alteheld B, Stehle P, et al. Safety and intestinal tolerance of highdose enteral antioxidants and glutamine peptides after upper gastrointestinal surgery. Eur J Clin Nutr 2005; 59:307-310.
46. Heyland DK, Dhaliwalm R, Day A, et al. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN J Parenter Enteral Nutr 2007; 31:109-118.
47. A prestudy for the large Canadian multicentre study combining enteral and parenteral glutamine supplementation that is coming up.
48. Andrews PJ, Avenell A, Noble DW, et al. Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial). Trials 2007; 8:25.
49. Heyland DK, Dhaliwal R, Day AG, et al. REducing Deaths due to OXidative Stress (the REDOXS study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. ProcNutr Soc 2006; 65:250-263.